| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.2780 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.2780 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.2780 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.2913 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.3928 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.4619 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.4895 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.5577 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.5581 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.5675 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.5945 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.6005 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.6221 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.6392 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.6551 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.6571 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.6628 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.6703 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.6721 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.6741 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.6764 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.6983 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7044 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7118 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7215 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7349 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7417 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7507 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7520 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7533 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7601 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7601 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7625 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7764 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7835 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7876 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7901 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7948 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7954 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.7986 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8378 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8463 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8487 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8506 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8523 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8540 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8623 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8628 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8683 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8693 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8733 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8843 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8874 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8904 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8939 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.8980 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.9136 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.9144 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.9192 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.9314 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.9350 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.9518 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.9692 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.9736 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.9839 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 0.9936 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.0064 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.0088 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.0214 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.0291 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.0307 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.0506 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.0592 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.0679 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.0689 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.0840 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.0973 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.1068 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.1106 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.1204 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.1218 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.1375 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.1464 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.1623 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.1726 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.1803 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.1910 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.1936 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.2019 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.2073 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.2112 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.2252 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.2432 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.2467 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.2470 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.2601 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.2605 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.2693 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.2785 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.2904 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.3153 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.3173 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.3191 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.3256 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.3317 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.3425 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.3513 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.3700 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.3859 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.4478 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.4489 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.4614 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.4848 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.5089 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.5294 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.5614 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.5804 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.5877 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.5915 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.6580 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.6654 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.6852 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.7440 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.7802 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.7902 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 1.8412 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 2.0367 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 2.4378 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 2.6873 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | 3-ureidopropionate | 2.8023 | Peak area | Obese neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|